Bullish option flow detected in TG Therapeutics with 11,644 calls trading, 4x expected, and implied vol increasing almost 3 points to 264.86%. Jan-23 35 calls and Jan-23 9 calls are the most active options, with total volume in those strikes near 6,200 contracts. The Put/Call Ratio is 0.20. Earnings are expected on February 28th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TGTX:
- 2 Biotech Stocks Under $10 That Could Win From Key FDA Approvals
- TG Therapeutics call volume above normal and directionally bullish
- Cellectar Biosciences appoints Lea as Chief Commercial Officer
- Here’s Why TG Therapeutics Shares (NASDAQ: TGTX) Surged Over 60%
- TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results